Cable Hill Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $310K | Sell |
722
-566
| -44% | -$307K | 0.03% | 135 |
|
|
2024
Q4 | $670K | Buy |
1,288
+166
| +15% | +$91.3K | 0.07% | 67 |
|
|
2024
Q3 | $694K | Sell |
1,122
-79
| -7% | -$46.8K | 0.07% | 66 |
|
|
2024
Q2 | $665K | Buy |
+1,201
| New | +$688K | 0.07% | 64 |
|
|
2023
Q4 | – | Sell |
-1,117
| Closed | -$565K | – | 232 |
|
|
2023
Q3 | $565K | Sell |
1,117
-88
| -7% | -$46.9K | 0.08% | 58 |
|
|
2023
Q2 | $629K | Sell |
1,205
-96
| -7% | -$51.8K | 0.08% | 59 |
|
|
2023
Q1 | $750K | Buy |
1,301
+2
| +0.2% | +$1.13K | 0.12% | 47 |
|
|
2022
Q4 | $716K | Sell |
1,299
-77
| -6% | -$40.8K | 0.13% | 53 |
|
|
2022
Q3 | $698K | Sell |
1,376
-51
| -4% | -$28.5K | 0.14% | 51 |
|
|
2022
Q2 | $775K | Sell |
1,427
-395
| -22% | -$217K | 0.19% | 48 |
|
|
2022
Q1 | $1.08M | Buy |
1,822
+175
| +11% | +$101K | 0.71% | 23 |
|
|
2021
Q4 | $1.1M | Buy |
1,647
+87
| +6% | +$54.3K | 0.23% | 42 |
|
|
2021
Q3 | $891K | Sell |
1,560
-1,260
| -45% | -$692K | 0.21% | 40 |
|
|
2021
Q2 | $1.42M | Buy |
2,820
+1,340
| +91% | +$632K | 0.34% | 26 |
|
|
2021
Q1 | $675K | Sell |
1,480
-75
| -5% | -$35.8K | 0.19% | 39 |
|
|
2020
Q4 | $724K | Sell |
1,555
-80
| -5% | -$37.5K | 0.2% | 33 |
|
|
2020
Q3 | $722K | Sell |
1,635
-45
| -3% | -$18.6K | 0.21% | 33 |
|
|
2020
Q2 | $609K | Hold |
1,680
| – | – | 0.2% | 32 |
|
|
2020
Q1 | $476K | Hold |
1,680
| – | – | 0.17% | 44 |
|
|
2019
Q4 | $546K | Sell |
1,680
-700
| -29% | -$212K | 0.16% | 45 |
|
|
2019
Q3 | $693K | Hold |
2,380
| – | – | 0.23% | 30 |
|
|
2019
Q2 | $699K | Sell |
2,380
-31
| -1% | -$8.54K | 0.24% | 32 |
|
|
2019
Q1 | $659K | Buy |
2,411
+296
| +14% | +$73.7K | 0.22% | 37 |
|
|
2018
Q4 | $473K | Buy |
2,115
+1,389
| +191% | +$326K | 0.19% | 47 |
|
|
2018
Q3 | $176K | Sell |
726
-150
| -17% | -$34.5K | 0.07% | 79 |
|
|
2018
Q2 | $182K | Hold |
876
| – | – | 0.08% | 83 |
|
|
2018
Q1 | $180K | Sell |
876
-45
| -5% | -$9.45K | 0.08% | 82 |
|
|
2017
Q4 | $183K | Hold |
921
| – | – | 0.08% | 92 |
|
|
2017
Q3 | $174K | Hold |
921
| – | – | 0.08% | 103 |
|
|
2017
Q2 | $161K | Sell |
921
-29
| -3% | -$4.87K | 0.09% | 67 |
|
|
2017
Q1 | $145K | Sell |
950
-5
| -0.5% | -$764 | 0.07% | 70 |
|
|
2016
Q4 | $135K | Sell |
955
-6
| -0.6% | -$885 | 0.06% | 74 |
|
|
2016
Q3 | $152K | Buy |
961
+205
| +27% | +$31.6K | 0.11% | 65 |
|
|
2016
Q2 | $114K | Hold |
756
| – | – | 0.08% | 77 |
|
|
2016
Q1 | $108K | Sell |
756
-65
| -8% | -$8.71K | 0.08% | 69 |
|
|
2015
Q4 | $118K | Hold |
821
| – | – | 0.08% | 67 |
|
|
2015
Q3 | $101K | Sell |
821
-15
| -2% | -$1.95K | 0.08% | 72 |
|
|
2015
Q2 | $110K | Hold |
836
| – | – | 0.08% | 74 |
|
|
2015
Q1 | $111K | Buy |
836
+156
| +23% | +$20.1K | 0.09% | 73 |
|
|
2014
Q4 | $85K | Buy |
+680
| New | +$82.7K | 0.08% | 83 |
|
Other funds holding TMO
Cable Hill Partners's TMO Position: Q1 2025 in Review
Cable Hill Partners reduced its Thermo Fisher Scientific (TMO) stake by 44% in Q1 2025, selling an estimated $307K and leaving 722 shares worth $310K. The position accounts for 0.03% of the portfolio, ranked #135.
Cable Hill Partners first reported a position in TMO in Q4 2014 and has held it in 40 quarters since. The position peaked at $1.42M in Q2 2021. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.
- Cable Hill Partners held 722 shares of Thermo Fisher Scientific worth $310K as of Q1 2025.
- Cable Hill Partners sold 566 Thermo Fisher Scientific shares in Q1 2025, an estimated $307K.
- Thermo Fisher Scientific made up 0.03% of Cable Hill Partners's portfolio in Q1 2025, its #135 holding.
- Cable Hill Partners first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 40 quarters since.
- Cable Hill Partners's Thermo Fisher Scientific position peaked at $1.42M in Q2 2021.
- 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.
Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.